BMS-986142

DB15291InvestigationalSmall molecule

BMS-986142 is under investigation in clinical trial NCT02880670 (Pharmacokinetics and Metabolism Study of Radiolabeled BMS-986142 in Healthy Male Subjects).

Mechanism: Pharmacologically active on Tyrosine-protein kinase BTK
Curator reviewed
Formula / weight: C₃₂H₃₀F₂N₄O₄ · 572.613 g/mol (avg)
Code names: BMS-986142

Resolves to

Compound

UNIIPJX9GH268RCAS1643368-58-4ChEMBLCHEMBL3900554

Structure

InChIKeyZRYMMWAJAFUANM-INIZCTEOSA-NSMILESCN1C(=O)N(C(=O)C2=C1C(F)=CC=C2)C1=C(C)C(=CC=C1)C1=C2C3=C(C[C@H](CC3)C(C)(C)O)NC2=C(C=C1F)C(N)=O

Targets

Q06187BTK

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with BMS-986142, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account